- Home
- EMR vs RNXT Comparison
EMR vs RNXT Comparison
Compare EMR & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMR
- RNXT
- Stock Information
- Founded
- EMR 1890
- RNXT 2012
- Country
- EMR United States
- RNXT United States
- Employees
- EMR N/A
- RNXT N/A
- Industry
- EMR Consumer Electronics/Appliances
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- EMR Technology
- RNXT Health Care
- Exchange
- EMR Nasdaq
- RNXT Nasdaq
- Market Cap
- EMR N/A
- RNXT 37.6M
- IPO Year
- EMR N/A
- RNXT 2021
- Fundamental
- Price
- EMR $112.55
- RNXT $1.06
- Analyst Decision
- EMR Buy
- RNXT Strong Buy
- Analyst Count
- EMR 15
- RNXT 2
- Target Price
- EMR $128.20
- RNXT $7.00
- AVG Volume (30 Days)
- EMR 3.0M
- RNXT 116.6K
- Earning Date
- EMR 05-07-2025
- RNXT 05-15-2025
- Dividend Yield
- EMR 1.88%
- RNXT N/A
- EPS Growth
- EMR N/A
- RNXT N/A
- EPS
- EMR 4.20
- RNXT N/A
- Revenue
- EMR $17,607,000,000.00
- RNXT $43,000.00
- Revenue This Year
- EMR $3.42
- RNXT $4,755.81
- Revenue Next Year
- EMR $4.95
- RNXT $187.93
- P/E Ratio
- EMR $32.50
- RNXT N/A
- Revenue Growth
- EMR 6.52
- RNXT N/A
- 52 Week Low
- EMR $90.06
- RNXT $0.75
- 52 Week High
- EMR $134.85
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- EMR 62.64
- RNXT 60.35
- Support Level
- EMR $106.53
- RNXT $1.02
- Resistance Level
- EMR $115.00
- RNXT $1.09
- Average True Range (ATR)
- EMR 3.10
- RNXT 0.05
- MACD
- EMR 1.48
- RNXT 0.01
- Stochastic Oscillator
- EMR 85.91
- RNXT 80.00
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.